Cogni-Q is a nutraceutical designed to support cognitive function with particular benefits on memory. The supplement is produced by Quality of Life, a company with a history of over 15 years in the field. The manufacturer prides itself with several awarded formulations such as AHCC-a patented medicinal mushroom extract, Oligonol- an innovative formula with anti-aging benefits, or VitaPQQ- the first dietary formula to feature the vitamin PQQ designed to preserve mitochondrial function. Quality of Life also claims to be dedicated to providing formulas that contain meaningful dosages of key ingredients, an essential condition of high-potency products.
Cogni-Q is based on a single active ingredient which is a patented extract of the Korean plant Angelica. The plant derived compound is known as INM-176 and is a clinically researched substance. The manufacturer claims this chemical has been shown in a published double-blind, placebo-controlled trial to support cognitive agility in 80 subjects suffering from mild memory problems associated with aging.
Cogni-Q contains the following ingredients: Cogni-Q contains the following ingredients: Angelica gigas Nakai (root) extract (INM-176), Decursin, Decursinol, rice flour, vegetable cellulose, and Leucine.
INM-176 is a standardized ethanolic extract of the plant Angelica gigas Nakai used as a traditional Korean remedy as a general tonic, to improve gynecological health, and support the immune and cardiovascular systems. Currently, the plant is being investigated as an anti-cancerous treatment, but its effectiveness has not yet been confirmed by clinical trials.
INM-176 has been primarily investigated as a neuroprotective agent in patients suffering from Alzheimer’s and other age-related cognitive problems. An animal study concluded that due to its anti-inflammatory action, the compound can be a potent neuroprotective and cognition ameliorating agent. Human trials have also shown positive outcomes. One of these studies is mentioned by the manufacturer on the official page of Cogni-Q. The subjects who were administered with the INM-176 compound had a significant decrease in total error score in the Alzheimer’s Disease Assessment Scale-Cognitive section as opposed to those who were administered with placebo. The INM-176 group was also favored by the mean changes in instrumental activities of daily living (IADL) and geriatric depression scale (GDS) as compared to the placebo group. Another study involving 92 participants (elder individuals suffering from cognitive impairment) showed similar results.
Scientists observed that INM-176 works by increasing Acetylcholine levels in the brain. AC is an important neurotransmitter involved in brain cell signaling. It is why without adequate amounts of AC in the brain, neuronal communication becomes impaired leading to memory problems and communication issues. Age related memory decline has also been associated with AC decline, so INM-176’s ability to help maintain Acetylcholine levels in the brain is essential for preventing memory problems.
Sale Price: $25.60
Free Trial* Available: No
- The formula is based on a patented and clinically researched compound which has shown positive outcomes in both animal and human trials.
- The formula is available at various online stores, some offering discounts.
- The monthly cost of Cogni-Q is moderately low.
- The manufacturer offers a restrictive return policy (only available for 30 days). Only unopened bottles are accepted.
- The number of consumer testimonials involving this formula is limited. A large percentage of the few consumers who reviewed the formula complain about the ineffectiveness of the supplement.
Cogni-Q looks like a high-quality formula because it is manufactured by an experience and awarded manufacturer, and it contains a single patented and clinically researched key-ingredient. However, the product does not benefit of the consumers support at this time. A reduced number of consumer testimonials are available for online consulting. The reviews are mixed. However, the existing clinical evidence seems to support INM-176’s antioxidant and neuroprotective benefits. More research is required in order to reach a definitive conclusion, as the number and scale of clinical trials conducted so far are reduced.